Chief Executive Officer
Current
Oct 2016 - Present
AeroLeads people directory · profile
Michael Gilman Email & Phone Number
Chief Executive Officer at Arrakis Therapeutics
at
Arrakis Therapeutics
1 work email found
@arrakistx.com
3 phones found area 574, 617, and 781
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 86%
Current company
Role
Chief Executive Officer at Arrakis Therapeutics
Location
Waban, Massachusetts, United States
Who is Michael Gilman? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Gilman is listed as Chief Executive Officer at Arrakis Therapeutics at Arrakis Therapeutics, based in Waban, Massachusetts, United States. AeroLeads shows a work email signal at arrakistx.com, phone signal with area code 574, 617, 781, and a matched LinkedIn profile for Michael Gilman.
Michael Gilman previously worked as Chief Executive Officer at Arrakis Therapeutics and Chief Executive Officer at Obsidian Therapeutics. Michael Gilman holds Ph.D., Biochemistry from University Of California, Berkeley.
Company email context
Email format at Arrakis Therapeutics
This section adds company-level context without repeating Michael Gilman's masked contact details.
{first_initial}{last}@arrakistx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Michael Gilman. Compare company email patterns before reaching out.
Profile bio
About Michael Gilman
Michael Gilman is a Chief Executive Officer at Arrakis Therapeutics at Arrakis Therapeutics. Colleagues describe him as "Michael Gilman has made two successful transitions: from academia (Cold Spring Harbor) to big biotech at Biogen (later Biogen Idec), where he rose to the head of research role; and from big biotech to venture-backed biotech in his current role as founder and CEO at Stromedix. It is unusual for someone to make one such successful switch, let alone two, though I am sure Mike would say that his success at Stromedix will be determined by the clinical data of their fibrosis product. But I measure success in other terms as well. Sovereignty over the financial, technical and interpersonal challenges of operating in the VC-backed biotech world is one metric. Clarity of thought and communication with colleagues, subordinates and service providers is another. Insight and wisdom about drug development and its pitfalls is a third. Against all these yardsticks, Mike's performance is superior. It has been a privilege to work with him through three career iterations - interviewing him on technical subjects when I was a biomedical writer; showing him technologies when I was in venture capital; and working on positioning strategy and fund-raising materials as a consultant. I continue to learn from Mike and to greatly enjoy his company and I recommend him highly to partners, investors and providers alike."
Current workplace
Michael Gilman's current company
Company context helps verify the profile and gives searchers a useful next step.
9 roles
Michael Gilman work experience
A career timeline built from the work history available for this profile.
Chief Executive Officer
Oct 2016 - Apr 2019
Founder And Chief Executive Officer
Padlock Therapeutics
Venture-backed startup focused on developing medicines for autoimmune diseases. Conceived and executed business strategy. Recruited and hired management team. Managed 12-month seed-investment period then transitioned company to full operations. Raised $23MM Series A round. Company acquired by Bristol-Myers Squibb in March 2016 for $225MM in upfront and.
Jan 2014 - Apr 2016
Senior Vice President, Early Stage Pipeline
Responsible for all matrixed program teams for development programs through clinical proof of concept, approximately ten programs with an aggregate annual budget of over $200MM. Member of Corporate Development and Senior R&D Leadership teams. Continued responsibility for Stromedix team.
Mar 2012 - Jun 2013
Founder And Chief Executive Officer
Stromedix, Inc.
Venture-backed startup focused on developing novel therapies for fibrosis and organ failure. Conceived, planned and executed business strategy. Commenced company operations in June 2007. Raised $38.5MM in venture financing. Recruited and hired management team. Negotiated and completed license for IND- stage monoclonal antibody developed by Biogen Idec..
Jun 2006 - Mar 2012
Executive Vice President, Research
Responsible for all discovery research activities at Cambridge and San Diego sites — staff of over 400, operating budget of $100MM, capital budget of $7MM. Established and executed integrated, commercially-relevant research strategy focusing on immunology, fibrosis, cancer and neurodegeneration; implemented effective project management system that.
May 1999 - Nov 2005
Executive Vice President And Chief Scientific Officer
Ariad Pharmaceuticals
Responsible for all drug discovery activities, including biology, pharmacology, medicinal and computational chemistry, biophysical sciences. Initiated and managed program to develop novel gene- and cell-regulation technology licensed from Harvard and Stanford for use in gene therapy; achieved proof of concept in non-human primates; first compound completed.
Aug 1994 - Mar 1999
Senior Staff Scientist
Principal Investigator with research programs in cancer, cell-cycle control, signal transduction and gene transcription; fully funded by NIH, ACS, private foundations; trained four graduate students and eleven postdoctoral fellows; adjunct academic appointments at SUNY Stony Brook; administered Cold Spring Harbor graduate student program.
Oct 1986 - Jul 1994
Postdoctoral Fellow
Laboratory of Dr. Robert Weinberg. Research program focused on cancer biology — oncogenes, growth control and signal transduction.
Sep 1983 - Sep 1986
2 education records
Michael Gilman education
Ph.D., Biochemistry
University Of California, Berkeley
S.B., Life Science
Massachusetts Institute Of Technology
FAQ
Frequently asked questions about Michael Gilman
Quick answers generated from the profile data available on this page.
What company does Michael Gilman work for?
Michael Gilman works for Arrakis Therapeutics.
What is Michael Gilman's role at Arrakis Therapeutics?
Michael Gilman is listed as Chief Executive Officer at Arrakis Therapeutics at Arrakis Therapeutics.
What is Michael Gilman's email address?
AeroLeads has found 1 work email signal at @arrakistx.com for Michael Gilman at Arrakis Therapeutics.
What is Michael Gilman's phone number?
AeroLeads has found 3 phone signal(s) with area code 574, 617, 781 for Michael Gilman at Arrakis Therapeutics.
Where is Michael Gilman based?
Michael Gilman is based in Waban, Massachusetts, United States while working with Arrakis Therapeutics.
What companies has Michael Gilman worked for?
Michael Gilman has worked for Arrakis Therapeutics, Obsidian Therapeutics, Padlock Therapeutics, Biogen Idec, and Stromedix, Inc..
How can I contact Michael Gilman?
You can use AeroLeads to view verified contact signals for Michael Gilman at Arrakis Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Michael Gilman attend?
Michael Gilman holds Ph.D., Biochemistry from University Of California, Berkeley.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial